These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 208068)

  • 1. Conformationally restricted bicyclic analogs of somatostatin.
    Veber DF; Holly FW; Paleveda WJ; Nutt RF; Bergstrand SJ; Torchiana M; Glitzer MS; Saperstein R; Hirschmann R
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2636-40. PubMed ID: 208068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of eighteen somatostatin analogues on gastric secretion.
    Brown MP; Coy DH; Gomez-Pan A; Hirst BH; Hunter M; Meyers C; Reed JD; Schally AV; Shaw B
    J Physiol; 1978 Apr; 277():1-14. PubMed ID: 349135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic and immunologic activities and applications of somatostatin analogs.
    Vale W; Rivier J; Ling N; Brown M
    Metabolism; 1978 Sep; 27(9 Suppl 1):1391-401. PubMed ID: 210361
    [No Abstract]   [Full Text] [Related]  

  • 5. Highly active cyclic and bicyclic somatostatin analogues of reduced ring size.
    Veber DF; Holly FW; Nutt RF; Bergstrand SJ; Brady SF; Hirschmann R; Glitzer MS; Saperstein R
    Nature; 1979 Aug; 280(5722):512-4. PubMed ID: 460433
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative effects of somatostatin and two somatostatin analogues on the release of insulin, glucagon and growth hormone.
    Efendić S; Luft R; Sievertsson H
    FEBS Lett; 1975 Oct; 58(1):302-5. PubMed ID: 1225595
    [No Abstract]   [Full Text] [Related]  

  • 7. Conformational modifications of cyclic hexapeptide somatostatin analogs.
    Freidinger RM; Perlow DS; Randall WC; Saperstein R; Arison BH; Veber DF
    Int J Pept Protein Res; 1984 Feb; 23(2):142-50. PubMed ID: 6142021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues.
    Coy DH; Meyers C; Arimura A; Schally AV; Redding TW
    Metabolism; 1978 Sep; 27(9 Suppl 1):1407-10. PubMed ID: 683009
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.
    Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats.
    Grant N; Clark D; Garsky V; Jaunakais I; McGregor W; Sarantakis D
    Life Sci; 1976 Sep; 19(5):629-31. PubMed ID: 957897
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of specific and non-specific somatostatin analogs.
    Nakano T; Harano Y; Emura J; Kimura T; Sakakibara S; Shigeta Y
    Horm Metab Res; 1986 Feb; 18(2):98-102. PubMed ID: 2870971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin agonists and antagonists--peptide control of growth hormone secretion.
    Coy DH; Murphy WA; Lance VA; Hocart SJ; Sueiras-Diaz J; Mezo I
    Adv Exp Med Biol; 1985; 188():325-37. PubMed ID: 2863940
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat.
    Fries JL; Murphy WA; Sueiras-Diaz J; Coy DH
    Peptides; 1982; 3(5):811-4. PubMed ID: 6129618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin analogs with improved oral bioavailability.
    Nutt RF; Colton CD; Veber DF; Slater EL; Saperstein R
    Klin Wochenschr; 1986; 64 Suppl 7():71-3. PubMed ID: 2882053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of new synthetic analogs of somatostatin on gastric secretion in the chronic fistula dog.
    Torchiana ML; Stone CA; Cook PG; Weise SJ
    Proc Soc Exp Biol Med; 1977 Mar; 154(3):449-52. PubMed ID: 847005
    [No Abstract]   [Full Text] [Related]  

  • 17. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs.
    Murphy WA; Meyers CA; Coy DH
    Endocrinology; 1981 Aug; 109(2):491-5. PubMed ID: 6113951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon releasing activity of a cyclic peptide related to somatostatin.
    Lyle TA; Freidinger RM; Nutt RF; Homnick CF; Saperstein R; Veber DF
    Int J Pept Protein Res; 1987 Feb; 29(2):244-9. PubMed ID: 2883151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natural peptides and their analogs. XXXV. Synthesis and properties of [Ala5, Orn9]somatostatin].
    Shvachkin IuP; Smirnova AP; Ermak NM; Fedotov VP; Sadovnikova NV
    Bioorg Khim; 1985 Aug; 11(8):1026-36. PubMed ID: 2865960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibitory effect of the analog D5-F-TrP8-D-Cys14 somatostatin on the arginine induced release of insulin, growth hormone and glucagon, in normal human beings.
    González-Bárcena D; Mendoza F; Graef A; Medina R; Comaru-Schally AM; Schally AV
    Arch Invest Med (Mex); 1985; 16 Suppl 3():105-14. PubMed ID: 2878649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.